Memantine ratiopharm 
Procedural steps taken and scientific information after the authorisation 
Application 
Scope 
number 
Opinion/ 
Commission 
Product 
Summary 
Notification
Decision 
Information 
1 issued on 
Issued 2 / 
affected 3  
amended 
on 
N/0023 
Minor change in labelling or package leaflet not 
03/06/2022 
PL 
connected with the SPC (Art. 61.3 Notification) 
IB/0022 
C.I.2.a - Change in the SPC, Labelling or PL of a 
12/11/2021 
generic/hybrid/biosimilar products following 
assessment of the same change for the reference 
SmPC, Annex 
II, Labelling 
1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions 
are issued for all other procedures. 
2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The 
CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures. 
3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet). 
Official address  Domenico Scarlattilaan 6  ●  1083 HS Amsterdam  ●  The Netherlands 
Address for visits and deliveries  Refer to www.ema.europa.eu/how-to-find-us  
Send us a question  Go to www.ema.europa.eu/contact   Telephone +31 (0)88 781 6000 
An agency of the European Union 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
product - Implementation of change(s) for which NO 
and PL 
new additional data is required to be submitted by 
the MAH 
IB/0021 
B.II.d.2.d - Change in test procedure for the finished 
05/08/2021 
n/a 
product - Other changes to a test procedure 
(including replacement or addition) 
IA/0020 
B.II.d.2.a - Change in test procedure for the finished 
03/05/2021 
n/a 
product - Minor changes to an approved test 
procedure 
IA/0019 
B.I.b.2.a - Change in test procedure for AS or 
21/10/2020 
n/a 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
IB/0018/G 
This was an application for a group of variations. 
14/08/2020 
n/a 
B.I.z - Quality change - Active substance - Other 
variation 
B.I.a.2.e - Changes in the manufacturing process of 
the AS - Minor change to the restricted part of an 
ASMF 
B.I.b.1.b - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Tightening of 
specification limits 
B.I.b.1.d - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Deletion of a non-
significant specification parameter (e.g. deletion of 
Page 2/9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
an obsolete parameter) 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.I.c.z - Container closure system of the AS - Other 
variation 
B.I.a.2.e - Changes in the manufacturing process of 
the AS - Minor change to the restricted part of an 
ASMF 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
IA/0017 
B.II.e.1.a.1 - Change in immediate packaging of the 
12/07/2019 
n/a 
finished product - Qualitative and quantitative 
composition - Solid pharmaceutical forms 
IA/0016 
A.7 - Administrative change - Deletion of 
26/10/2018 
n/a 
manufacturing sites 
Page 3/9 
 
 
 
 
 
 
 
 
 
 
 
N/0015 
Minor change in labelling or package leaflet not 
24/07/2018 
PL 
connected with the SPC (Art. 61.3 Notification) 
R/0011 
Renewal of the marketing authorisation. 
22/02/2018 
13/04/2018 
SmPC, 
Labelling and 
PL 
II/0012 
To introduce PLIVA Croatia Ltd. TAPI Croatia 
15/03/2018 
n/a 
Production SM, Prudnička cesta 54 10291, Prigorje, 
Brdovečko, Croatia as additional manufacturer of the 
active substance supported by an ASMF. 
B.I.a.1.b - Change in the manufacturer of AS or of a 
starting material/reagent/intermediate for AS - 
Introduction of a manufacturer of the AS supported 
by an ASMF 
IA/0014 
A.7 - Administrative change - Deletion of 
11/01/2018 
n/a 
manufacturing sites 
IAIN/0013/G 
This was an application for a group of variations. 
20/11/2017 
13/04/2018 
SmPC and PL 
B.II.a.1.a - Change or addition of imprints, bossing 
or other markings including replacement, or addition 
of inks used for product marking - Changes in 
imprints, bossing or other markings 
B.II.d.1.d - Change in the specification parameters 
and/or limits of the finished product - Deletion of a 
non-significant specification parameter 
Page 4/9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
II/0008 
B.II.d.1 e) To change the shelf-life specification for 
20/07/2017 
n/a 
Memantine HCl 5 mg, 10 mg, 15 mg and 20 mg film-
coated tablets by widening the water content limit 
from NMT 5.0 % to NMT 6.0 % 
B.II.d.1.e - Change in the specification parameters 
and/or limits of the finished product - Change 
outside the approved specifications limits range 
IA/0010 
A.7 - Administrative change - Deletion of 
30/05/2017 
n/a 
manufacturing sites 
IB/0009 
B.II.b.3.z - Change in the manufacturing process of 
23/05/2017 
n/a 
the finished or intermediate product - Other variation 
IB/0007/G 
This was an application for a group of variations. 
05/04/2017 
n/a 
B.II.b.3.a - Change in the manufacturing process of 
the finished or intermediate product - Minor change 
in the manufacturing process 
B.II.b.3.z - Change in the manufacturing process of 
the finished or intermediate product - Other variation 
IB/0006 
C.I.z - Changes (Safety/Efficacy) of Human and 
28/06/2016 
09/08/2016 
SmPC, Annex 
Veterinary Medicinal Products - Other variation 
II, Labelling 
and PL 
IB/0005/G 
This was an application for a group of variations. 
24/02/2016 
n/a 
B.I.a.1.a - Change in the manufacturer of AS or of a 
starting material/reagent/intermediate for AS - The 
proposed manufacturer is part of the same 
Page 5/9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
pharmaceutical group as the currently approved 
manufacturer 
B.I.a.1.a - Change in the manufacturer of AS or of a 
starting material/reagent/intermediate for AS - The 
proposed manufacturer is part of the same 
pharmaceutical group as the currently approved 
manufacturer 
B.I.a.2.a - Changes in the manufacturing process of 
the AS - Minor change in the manufacturing process 
of the AS 
B.I.a.2.e - Changes in the manufacturing process of 
the AS - Minor change to the restricted part of an 
ASMF 
B.I.a.2.e - Changes in the manufacturing process of 
the AS - Minor change to the restricted part of an 
ASMF 
B.I.a.2.z - Changes in the manufacturing process of 
the AS - Other variation 
B.I.a.3.a - Change in batch size (including batch size 
ranges) of AS or intermediate - Up to 10-fold 
increase compared to the originally approved batch 
size 
B.I.a.3.a - Change in batch size (including batch size 
ranges) of AS or intermediate - Up to 10-fold 
increase compared to the originally approved batch 
size 
B.I.b.1.b - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Tightening of 
specification limits 
B.I.b.1.b - Change in the specification parameters 
and/or limits of an AS, starting 
Page 6/9 
 
 
 
 
 
material/intermediate/reagent - Tightening of 
specification limits 
B.I.b.2.e - Change in test procedure for AS or 
starting material/reagent/intermediate - Other 
changes to a test procedure (including replacement 
or addition) for the AS or a starting 
material/intermediate 
B.I.z - Quality change - Active substance - Other 
variation 
B.I.z - Quality change - Active substance - Other 
variation 
B.I.a.1.i - Change in the manufacturer of AS or of a 
starting material/reagent/intermediate for AS - 
Introduction of a new site of micronisation 
B.I.a.1.i - Change in the manufacturer of AS or of a 
starting material/reagent/intermediate for AS - 
Introduction of a new site of micronisation 
B.I.a.2.a - Changes in the manufacturing process of 
the AS - Minor change in the manufacturing process 
of the AS 
B.I.a.4.c - Change to in-process tests or limits 
applied during the manufacture of the AS - Deletion 
of a non-significant in-process test 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.I.b.2.e - Change in test procedure for AS or 
starting material/reagent/intermediate - Other 
changes to a test procedure (including replacement 
or addition) for the AS or a starting 
material/intermediate 
B.I.b.2.e - Change in test procedure for AS or 
Page 7/9 
 
 
 
 
 
starting material/reagent/intermediate - Other 
changes to a test procedure (including replacement 
or addition) for the AS or a starting 
material/intermediate 
IB/0004 
B.II.f.1.a.1 - Stability of FP - Reduction of the shelf 
14/08/2015 
09/08/2016 
SmPC 
life of the finished product - As packaged for sale 
IA/0003 
B.II.e.6.b - Change in any part of the (primary) 
07/08/2015 
n/a 
packaging material not in contact with the finished 
product formulation - Change that does not affect 
the product information 
II/0002/G 
This was an application for a group of variations. 
26/03/2015 
n/a 
B.II.b.5.d - Change to in-process tests or limits 
applied during the manufacture of the finished 
product - Deletion of an in-process test which may 
have a significant effect on the overall quality of the 
finished product 
B.II.b.5.z - Change to in-process tests or limits 
applied during the manufacture of the finished 
product - Other variation 
B.II.d.2.f - Change in test procedure for the finished 
product - To reflect compliance with the Ph. Eur. and 
remove reference to the outdated internal test 
method and test method number 
B.II.d.2.f - Change in test procedure for the finished 
product - To reflect compliance with the Ph. Eur. and 
remove reference to the outdated internal test 
method and test method number 
Page 8/9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B.II.d.2.f - Change in test procedure for the finished 
product - To reflect compliance with the Ph. Eur. and 
remove reference to the outdated internal test 
method and test method number 
IB/0001 
B.II.f.1.d - Stability of FP - Change in storage 
16/12/2013 
15/01/2015 
SmPC, 
conditions of the finished product or the 
diluted/reconstituted product 
Labelling and 
PL 
Page 9/9 
 
 
 
 
 
 
 
 
 
